Cargando…

Comparative role of tenofovir versus entecavir for treating patients with hepatitis B virus-related acute on chronic liver failure

INTRODUCTION: The aim of the study was to compare the safety and efficacy of tenofovir versus entecavir for treatment of naive acute on chronic liver failure (ACLF) due to hepatitis B virus (HBV) (ACLF-B). METHODS: Thirty-two patients aged 14-65 years were enrolled in the study. Diagnosis of ACLF wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hossain, Sharker M. S., Mahtab, Mamun A., Das, Dulal C., Noor-E-Alam, Sheikh M., Mamun, Ayub A., Khan, Md. Sakirul I., Akbar, Sheikh M. F., Rahman, Md Zakiur, Rahman, Salimur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415666/ https://www.ncbi.nlm.nih.gov/pubmed/34568149 http://dx.doi.org/10.4103/jfmpc.jfmpc_2299_20

Ejemplares similares

Role of tenofovir and telbivudine in treatment of hepatitis B related acute on chronic liver failure
por: Malakar, Debraj, et al.
Publicado: (2021)

Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure
por: Manik, Abul H, et al.
Publicado: (2021)

Effect of Granulocyte Colony-stimulating Factor and Erythropoietin on Patients with Acute-on-chronic Liver Failure
por: Haque, Md Nazmul, et al.
Publicado: (2020)

A Case of Antimitochondrial Antibody Negative Primary Biliary Cirrhosis from Bangladesh and Review of Literature
por: Begum, Roksana, et al.
Publicado: (2015)

Budd–Chiari Syndrome Due to Protein C Deficiency: A Rare Disorder to cause Chronic Liver Disease
por: Begum, Rukshana, et al.
Publicado: (2016)

Tele-education for hepatology residents in Bangladesh during the Covid-19 pandemic
por: Mahtab, Mamun A., et al.
Publicado: (2020)

Healthcare for non-Covid-19 liver disease patients during the Covid-19 pandemic in Bangladesh: Current trend and future implications
por: Faizul Huq, A. K. M., et al.
Publicado: (2020)

Epidemiology of Hepatitis E Virus in an Urban Community in Dhaka City
por: Rahman, Salimur, et al.
Publicado: (2014)

The Evaluation of Serum Ascites Albumin Gradient and Portal Hypertensive changes in Cirrhotic Patients with Ascites
por: Shahed, Forhad Hossain Md, et al.
Publicado: (2016)

Nobel Prize for the Discovery of Hepatitis B and C: A Brief History in Time
por: Al-Mahtab, Mamun, et al.
Publicado: (2020)

The Value of Serum CA19-9 Levels in predicting Extent of Hepatic Fibrosis in Patients with Chronic Hepatitis B
por: Haque, Mohammad Sayedul, et al.
Publicado: (2015)

Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy
por: MF Akbar, Sheikh, et al.
Publicado: (2018)

Plasma Exchange in Patients of Acute on Chronic Liver Failure: An Observational Study in Bangladesh
por: Mukit, Abdullah Al, et al.
Publicado: (2022)

An Outbreak of Acute Hepatitis in a Medical Facility of Bangladesh
por: Al Mahtab, Mamun, et al.
Publicado: (2014)

Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2023)

A Case Report of Decompensated Cirrhosis of Liver with Sideroblastic Anemia
por: Mahtab, Mamun-Al, et al.
Publicado: (2015)

Chronic Liver Disease is One of the Leading Causes of Death in Bangladesh: Experience by Death Audit from a Tertiary Hospital
por: Abedin, Mohammed Forhad, et al.
Publicado: (2014)

Biochemical Scoring System for diagnosing Nonalcoholic Steatohepatitis
por: Noor-E-Alam, Mohammad, et al.
Publicado: (2016)

Development of Therapeutic Vaccine for Chronic Hepatitis B: Concept, Cellular and Molecular Events, Design, Limitation, and Future Projection
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2022)

High Prevalence of Wilson's Diseases with Low Prevalence of Kayser–Fleischer Rings among Patients with Cryptogenic Chronic Liver Diseases in Bangladesh
por: Choudhury, Nuzhat, et al.
Publicado: (2019)

HEV Infection as an Aetiologic Factor for Acute Hepatitis: Experience from a Tertiary Hospital in Bangladesh
por: Mamun-Al-Mahtab,, et al.
Publicado: (2009)

Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2021)

Stem Cell Therapy for Cirrhosis of Liver in Bangladesh: Specific Design Compatible for Developing Country
por: Al Mahtab, Mamun, et al.
Publicado: (2018)

Extraordinary Survival Benefits of Severe and Critical Patients with COVID-19 by Immune Modulators: The Outcome of a Clinical Trial in Bangladesh
por: Islam, Md Azizul, et al.
Publicado: (2020)

Prevalence of Hepatitis B Virus and Hepatitis C Virus in a Tea Garden of Bangladesh
por: Al Mahtab, Mamun, et al.
Publicado: (2017)

Treatment by Transarterial Chemoembolization and Sorafenib for Hepatocellular Carcinoma vs Advanced Hepatocellular Carcinoma in Bangladesh: A Real-life Situation
por: Al Mahtab, Mamun, et al.
Publicado: (2019)

Risk of congenital birth defects during COVID-19 pandemic: Draw attention to the physicians and policymakers
por: Khan, Md Sakirul Islam, et al.
Publicado: (2020)

Unprecedented rise of monkeypox in Europe and America: Are Asian countries ready for a new outbreak during the ongoing COVID-19 pandemic?
por: Khan, Sakirul, et al.
Publicado: (2022)

Relationship between Hepatitis B Viral Deoxyribonucleic Acid Load and Hepatocellular Carcinoma
por: M Hussain, Muhammad, et al.
Publicado: (2017)

Role of Pegylated Interferon in Patients with Chronic Liver Diseases in the Context of SARS-CoV-2 Infection
por: Akbar, Sheikh MF, et al.
Publicado: (2021)

Innovative Therapies Targeting the Virus and the Host for Treating Chronic Hepatitis B Virus Infection: From Bench to Bedside
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2022)

Safety profile, antiviral capacity, and liver protection of a nasal therapeutic vaccine in patients with chronic hepatitis B: Five-year-follow-up outcomes after the end of treatment
por: Al Mahtab, Mamun, et al.
Publicado: (2023)

Comparable efficacy with entecavir monotherapy and tenofovir–entecavir combination in chronic hepatitis B patients
por: Baqai, Sumbella, et al.
Publicado: (2015)

Reply to “Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19”
por: Khan, Md. Saiful Islam, et al.
Publicado: (2021)

Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
por: Khan, Md. Saiful Islam, et al.
Publicado: (2020)

Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
por: Khan, Md. Saiful Islam, et al.
Publicado: (2020)

Real-life Management Strategy of COVID-19 Patients in Bangladesh with No Death: An Observational and Cohort Study
por: Faizul Huq, AKM, et al.
Publicado: (2020)

Recent downhill course of COVID-19 at Rohingya refugee camps in Bangladesh: Urgent action solicited
por: Khan, Sakirul, et al.
Publicado: (2021)

Dengue Infections during COVID-19 Period: Reflection of Reality or Elusive Data Due to Effect of Pandemic
por: Khan, Sakirul, et al.
Publicado: (2022)

Treatment of COVID-19 Patients at a Medical College Hospital in Bangladesh
por: Bhuyan, Muhammad AR, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dvbbjbstvksqm8hskcti08da51